Halozyme Therapeutics (HALO) Sales of Property, Plant and Equipment (2012 - 2022)

Halozyme Therapeutics (HALO) Sales of Property, Plant and Equipment (2012 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Sales of Property, Plant and Equipment (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 27,000.00
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Halozyme Therapeutics 9.65 Bn 9.33 Bn 297.47 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 9.99 Mn
Dec 31, 2022 9.99 Mn
Dec 31, 2020 215,000.00
Dec 31, 2020 215,000.00
Sep 30, 2020 123,000.00
Sep 30, 2020 123,000.00
Mar 31, 2020 738,000.00
Mar 31, 2020 738,000.00
Mar 31, 2012 15,844.00
Mar 31, 2012 15,844.00